icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
cKUE8yLJfjxg2QdR